Archives of Endocrinology and Metabolism (Jun 2020)

Cost effectiveness of intraoperative pathology in the management of indeterminate thyroid nodules

  • Christopher D. Vuong,
  • WayAnne B. Watson,
  • Daniel I. Kwon,
  • Sonia S. Mohan,
  • Mia N. Perez,
  • Steve C. Lee,
  • Alfred A. Simental

DOI
https://doi.org/10.20945/2359-3997000000263
Journal volume & issue
Vol. 64, no. 4
pp. 356 – 361

Abstract

Read online

ABSTRACT Objective This study aims to determine the cost effectiveness of rapid frozen section (RFS) for indeterminate thyroid nodules. Materials and methods A retrospective chart review was conducted between January 2009 and June 2013 at a tertiary care institution. Main outcomes were number needed to treat, RFS efficacy, and cost-savings of avoiding second completion thyroidectomy. Cost-effectiveness was estimated using 2015 Medicare reimbursement rate. Results Out of 1,114 patients undergoing thyroid surgery, 314 had preoperative AUS/FLUS cytopathology and subsequent thyroid lobectomy with RFS. RFS identified 13 of the 32 patients with malignancy resulting in a total thyroidectomy. 19 of the 29 malignancies not detected by RFS were papillary microcarcinomas. Conclusions Completion thyroidectomy was avoided in 1 out of every 24 patients resulting in cost-savings of $ 80.04 per patient. In the era of outpatient thyroid surgery, intraoperative RFS for indeterminate thyroid nodules is cost-effective.

Keywords